1. Home
  2. CVCO vs TLX Comparison

CVCO vs TLX Comparison

Compare CVCO & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CVCO

Cavco Industries Inc. When Issued

HOLD

Current Price

$564.51

Market Cap

3.5B

ML Signal

HOLD

Logo Telix Pharmaceuticals Limited American Depositary Shares

TLX

Telix Pharmaceuticals Limited American Depositary Shares

HOLD

Current Price

$9.44

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVCO
TLX
Founded
1965
2015
Country
United States
Australia
Employees
N/A
1184
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.6B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
CVCO
TLX
Price
$564.51
$9.44
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$550.00
$21.13
AVG Volume (30 Days)
132.0K
131.9K
Earning Date
05-21-2026
08-19-2026
Dividend Yield
N/A
N/A
EPS Growth
15.79
N/A
EPS
23.98
N/A
Revenue
$2,142,713,000.00
N/A
Revenue This Year
$14.66
N/A
Revenue Next Year
$7.70
N/A
P/E Ratio
$24.12
$150.33
Revenue Growth
31.68
N/A
52 Week Low
$393.53
$6.28
52 Week High
$713.01
$17.25

Technical Indicators

Market Signals
Indicator
CVCO
TLX
Relative Strength Index (RSI) 64.25 44.96
Support Level $543.52 $8.79
Resistance Level $604.08 $9.92
Average True Range (ATR) 23.74 0.23
MACD 5.81 -0.03
Stochastic Oscillator 76.74 48.10

Price Performance

Historical Comparison
CVCO
TLX

About CVCO Cavco Industries Inc. When Issued

Cavco Industries Inc designs and produces factory-built homes under the Cavco Homes, Fleetwood Homes, and Palm Harbor Homes brands. It also produces modular homes, park model homes, and vacation cabins, as well as commercial structures, among others. The company operates principally in two segments: Factory-built housing, which includes wholesale and retail systems-built housing operations, and the Financial services segment, which includes manufactured housing consumer finance and insurance. Cavco receives a majority of its revenue from the Factory-built housing segment.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: